A notable trend is that DexP-nMIC formulations ( Figure 4 , blue columns) already inhibited about 50% of IL-6 secretion at the dose corresponding to 0.10 μg/mL of free Dexa, while DexSP needed a higher dose to be similarly effective ( Figure 4 , orange columns).
← all excerpts
Drug-Integrating Amphiphilic Nano-Assemblies: 3. PEG-PPS/Palmitate Nanomicelles for Sustained and Localized Delivery of Dexamethasone in Cell and Tissue Transplantations.
1
—
—